[ET Net News Agency, 20 August 2026] FOSUN PHARMA (02196) rose 10% to HK$18.41.
It hits an intra-day high of HK$18.42, hitting an 1-month high, breaking above the 100-D SMA of HK$17.235, and an intra-day low of HK$17.42. The total shares traded was 8.62 million, with a value of HK$155.17m. The active buy/sell ratio is 66:34, with net buying turnover of HK$47.65m. HAITONG INT'L SEC accounts for greatest net responsive buying turnover of HK$3.8m, with volume weighted average price of HK$18.096. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$25.35m, with volume weighted average price of HK$18.027.
Basic Information| Nominal | 18.410 | % Chg | +9.98% |
| High | 18.420 | Low | 17.420 |
| Shares Tr | 8.62m | Turnover | 155.17m |
| 10-D SMA | 17.102 | %H.V | 20.347 |
| 20-D SMA | 16.742 | VWAP | 18.001 |
| 50-D SMA | 16.165 | RSI14 | 72.901 |
Status: Breaking above the 100-D SMA, hitting an 1-month high, active buy/sell ratio is 66:34, with net buying turnover of HK$47.65m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| FOSUN PHARMA (02196) | 18.410 | +9.98 |
| SIHUAN PHARM (00460) | 0.915 | +7.65 |
| GRAND PHARMA (00512) | 5.680 | +7.98 |
| SBP GROUP (01177) | 5.590 | +16.70 |
| HENGRUI PHARMA (01276) | 52.250 | -4.91 |
| LIVZON PHARMA (01513) | 25.880 | +3.19 |
| LUYE PHARMA (02186) | 2.180 | +9.55 |
| SH PHARMA (02607) | 11.730 | +1.73 |
| CHINARES PHARMA (03320) | 5.000 | +2.88 |
| HANSOH PHARMA (03692) | 34.500 | +4.61 |
(ed)
